ConductScience.org, home

Paper17154643

A review of calcium channel antagonists in the treatment of pediatric hypertension.

Sahney S. Paediatr Drugs, 2006. Cited by 26 papers, by iCite.

Cite this record

ConductScience Library. A review of calcium channel antagonists in the treatment of pediatric hypertension. Papers, record 17154643. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17154643

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A review of calcium channel antagonists in the treatment of pediatric hypertension.
PubMed
Journal
Paediatr Drugs
PubMed
Year
2006
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
26
iCite
Relative citation ratio, by iCite
0.91
iCite
Revised in PubMed
2018-11-13
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sahney SShobha

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Calcium Channel BlockersMajor topic
HypertensionMajor topic
Amiodarone
Child
Felodipine
Humans
Isradipine
Nicardipine
Nifedipine
Verapamil

Source PubMed

Download CSV of topics

References102

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
19249636Regression of nifedipine-induced gingival hyperplasia following switch to a same class calcium channel blocker, isradipine.J Periodontol1997https://conductscience.org/library/papers/9249636PubMed
211304651Nicardipine to control mean arterial pressure after cardiothoracic surgery in infants and children.Am J Ther2001https://conductscience.org/library/papers/11304651PubMed
37637142The risk of myocardial infarction associated with antihypertensive drug therapies.JAMA1995https://conductscience.org/library/papers/7637142PubMed
48521773Amlodipine. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disease.Drugs1995https://conductscience.org/library/papers/8521773PubMed
59561341The classification of calcium antagonists and their selection in the treatment of hypertension. A reappraisal.Drugs1998https://conductscience.org/library/papers/9561341PubMed
66637932Nifedipine in hypertensive emergencies of children.Am J Dis Child1983https://conductscience.org/library/papers/6637932PubMed
73221006Treatment of hypertensive crisis in children with nifedipine.Intensive Care Med1988https://conductscience.org/library/papers/3221006PubMed
81989801Efficacy and safety of intravenous nicardipine in the control of postoperative hypertension. IV Nicardipine Study Group.Chest1991https://conductscience.org/library/papers/1989801PubMed
93797155Report of the Second Task Force on Blood Pressure Control in Children--1987. Task Force on Blood Pressure Control in Children. National Heart, Lung, and Blood Institute, Bethesda, Maryland.Pediatrics1987https://conductscience.org/library/papers/3797155PubMed
108643207Therapeutic efficacy of different antihypertensive drugs in human diabetic nephropathy: an updated meta-analysis.Nephrol Dial Transplant1995https://conductscience.org/library/papers/8643207PubMed
118885941
Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents.
Pediatrics1996https://conductscience.org/library/papers/8885941PubMed
122666449New therapeutic modalities in hypertension: focus on a new calcium antagonist-nicardipine.J Clin Pharmacol1989https://conductscience.org/library/papers/2666449PubMed
1312003700The use of calcium antagonists in the treatment of hypertensive persons with kidney disease.Curr Hypertens Rep2002https://conductscience.org/library/papers/12003700PubMed
143544786Short- and long-term effects of calcium entry blockers on the kidney.Am J Cardiol1987https://conductscience.org/library/papers/3544786PubMed
1510562973Use of calcium-channel blockers in pediatric renal transplant recipients.Pediatr Transplant1999https://conductscience.org/library/papers/10562973PubMed
169607186Antihypertensive treatment of patients with proteinuric renal diseases: risks or benefits of calcium channel blockers?Kidney Int1998https://conductscience.org/library/papers/9607186PubMed
179273824
Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a meta-analysis of randomized trials. Angiotensin-Converting-Enzyme Inhibition and Progressive Renal Disease Study Group.
Ann Intern Med1997https://conductscience.org/library/papers/9273824PubMed
182467131Pharmacokinetics of amlodipine in renal impairment.J Cardiovasc Pharmacol1988https://conductscience.org/library/papers/2467131PubMed
191711448Amlodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular disease.Drugs1991https://conductscience.org/library/papers/1711448PubMed
2010231447Class differences in the effects of calcium channel blockers in the rat remnant kidney model.Kidney Int1999https://conductscience.org/library/papers/10231447PubMed

See all 102 referencesDownload CSV of references

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.

PMIDTitleJournalYearIn PapersSource
42080794Suppression of Calcium Influx Reduces Coxsackievirus B3 Lethality With Elevated Interferon Beta Responses in Mice.J Med Virol2026https://conductscience.org/library/papers/42080794PubMed
40061283Combinatorial approach to treat iron overload cardiomyopathy in pediatric patients with thalassemia-major: A systematic review and meta-analysis.World J Cardiol2025https://conductscience.org/library/papers/40061283PubMed
38371660Pediatric antiarrhythmics and toxicity: A clinical review.J Am Coll Emerg Physicians Open2024https://conductscience.org/library/papers/38371660PubMed
37731443Calcium Channel Blocker Overdose Causes Acute Respiratory Distress Syndrome and Acute Kidney Injury in a 15-Year-Old Female.Cureus2023https://conductscience.org/library/papers/37731443PubMed
36839878Virtual Clinical Trials Guided Design of an Age-Appropriate Formulation and Dosing Strategy of Nifedipine for Paediatric Use.Pharmaceutics2023https://conductscience.org/library/papers/36839878PubMed
36677842Synthesis of Dihydropyrimidines: Isosteres of Nifedipine and Evaluation of Their Calcium Channel Blocking Efficiency.Molecules2023https://conductscience.org/library/papers/36677842PubMed
33194923Hypertensive Crisis in Pediatric Patients: An Overview.Front Pediatr2020https://conductscience.org/library/papers/33194923PubMed
31676933Antihypertensive agents: a long way to safe drug prescribing in children.Pediatr Nephrol2020https://conductscience.org/library/papers/31676933PubMed
28256607The Rotavirus NSP4 Viroporin Domain is a Calcium-conducting Ion Channel.Sci Rep2017https://conductscience.org/library/papers/28256607PubMed
27621495Stability of Extemporaneously Compounded Amlodipine Besylate Oral Suspensions.Can J Hosp Pharm2016https://conductscience.org/library/papers/27621495PubMed
24908135Pediatric hypertensive emergencies.Curr Hypertens Rep2014https://conductscience.org/library/papers/24908135PubMed
20233185Superior palatability of crushed lercanidipine compared with amlodipine among children.Br J Clin Pharmacol2010https://conductscience.org/library/papers/20233185PubMed
19876599Inhibition of MDR1 activity and induction of apoptosis by analogues of nifedipine and diltiazem: an in vitro analysis.Invest New Drugs2011https://conductscience.org/library/papers/19876599PubMed
18052411Systemic hypertension and proteinuria in childhood chronic renal parenchymal disease: role of antihypertensive drug management.Paediatr Drugs2007https://conductscience.org/library/papers/18052411PubMed
17990006Hypertension in children with chronic kidney disease: pathophysiology and management.Pediatr Nephrol2008https://conductscience.org/library/papers/17990006PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CYP3A41576PubTator's text mininghttps://conductscience.org/library/genes/1576NCBI Gene
CYP4F34051PubTator's text mininghttps://conductscience.org/library/genes/4051NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17154643

GET https://conductscience.org/api/papers/v1/17154643/references?page=2